Tag Archives: NDMA
-
-
Generic Valsartan Shortages Following Contamination Recalls Lead FDA To Prioritize Approval of New Drugs
-
Valsartan Contamination Lawsuits Stayed Pending Entry of Case Management Order
-
Colorectal Cancer from Valsartan Contamination Resulted in Wrongful Death, Lawsuit Alleges
-
Valsartan and Losartan Recalls Expanded As New Potentially Cancer-Causing Impurities Found
-
Stomach Cancer Lawsuit Filed Against Manufacturers of Recalled Generic Valsartan
-
Generic Drug Safety Concerns Refuted By FDA Amid Continuing Valsartan Recall Problems
-
Valsartan Impurity Problems May Have Resulted From Attempts to Increase Yield: Report
-
Valsartan Recall Lawsuits Centralized in Federal Multidistrict Litigation
-
Recalled Valsartan Tablets Led To Colorectal Cancer Diagnosis, Lawsuit Claims